SCHEMBL1191102

SCHEMBL1191102

CC(=S)c1ccccc1.CCc1ccc2ccc3cccc4ccc1c2c34

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
ALDH1A1 P00352 5/20 0.41
KDM4E B2RXH2 5/20 0.41
HPGD P15428 4/20 0.41
MAPT P10636 1/20 0.41
FAAH O00519 1/20 0.40
HSD17B10 Q99714 4/20 0.39
CYP1A2 P05177 4/20 0.39
POLB P06746 2/20 0.39
CYP2D6 P10635 2/20 0.39
GLA P06280 1/20 0.39
PPARG P37231 1/20 0.39
TDP1 Q9NUW8 2/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ERBB2 P04626 1/20 0.37
FYN P06241 1/20 0.37
MAOA P21397 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL308577 0.82 KMT2A (0.56) KMT2AMEN1ALDH1A1KDM4EHPGD
Ammonia Solution, Strong SCHEMBL29156709 0.81 KMT2A (0.54) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL11338015 0.74 ALDH1A1 (0.71) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL6046939 0.71 KMT2A (0.57) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL3802698 0.71 KMT2A (0.45) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL10700702 0.71 KMT2A (0.51) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL28943977 0.71 ALDH1A1 (0.45) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL1618749 0.70 ALDH1A1 (0.43) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL29521196 0.69 KMT2A (0.68) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL1275568 0.69 KMT2A (0.68) KMT2AMEN1ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169208-B2 Aromatic and aromatic/heteroaromatic molecular structures with controllable electron conducting properties E I DU PONT DE NEMOURS AND COMPANY (US) 2015-10-27 US disclosed
US-20120135249-A1 AROMATIC AND AROMATIC/HETEROAROMATIC MOLECULAR STRUCTURES WITH CONTROLLABLE ELECTRON CONDUCTING PROPERTIES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2012-05-31 US disclosed
US-20110024691-A1 AROMATIC AND AROMATIC/HETEROAROMATIC MOLECULAR STRUCTURES WITH CONTROLLABLE ELECTRON CONDUCTING PROPERTIES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-02-03 US disclosed
US-7638632-B2 4-Ethynyl (1,2-dicyanobenzene)-4'-Ethynylphenyl-1(4,5-dicyanobenzene); 1,4-Bis(4-pyridyl)butadiyne; 4-ethynyl(pyridine)-4'-ethynylnaphthalene-1-pyridine; self-assembled mono-, multilayers/ supramolecular objects; three-terminal devices; logic switches;nanoelectronic ; computers; wires; dielectrics E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-12-29 US disclosed
US-20090270627-A1 AROMATIC AND AROMATIC/HETEROAROMATIC MOLECULAR STRUCTURES WITH CONTROLLABLE ELECTRON CONDUCTING PROPERTIES FRENCH ROGER HARQUAIL 2009-10-29 US disclosed
US-20040138467-A1 Aromatic and aromatic/heteroaromatic molecular structures with controllable electron conducting properties E.I. DU PONT DE NEMOURS AND COMPANY 2004-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138467-A1 Aromatic and aromatic/heteroaromatic molecular structures with controllable electron conducting properties AHR, TYR, ARNT KMT2A 1939/4885MEN1 4135/4885ALDH1A1 1042/4885
US-20120135249-A1 AROMATIC AND AROMATIC/HETEROAROMATIC MOLECULAR STRUCTURES WITH CONTROLLABLE ELECTRON CONDUCTING PROPERTIES AHR, TYR, ARNT KMT2A 1939/4885MEN1 4135/4885ALDH1A1 1042/4885
US-20110024691-A1 AROMATIC AND AROMATIC/HETEROAROMATIC MOLECULAR STRUCTURES WITH CONTROLLABLE ELECTRON CONDUCTING PROPERTIES AHR, TYR, ARNT KMT2A 1939/4885MEN1 4135/4885ALDH1A1 1042/4885
US-20090270627-A1 AROMATIC AND AROMATIC/HETEROAROMATIC MOLECULAR STRUCTURES WITH CONTROLLABLE ELECTRON CONDUCTING PROPERTIES AHR, TYR, ARNT KMT2A 1939/4885MEN1 4135/4885ALDH1A1 1042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.